$PIRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PIERIS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PIERIS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in PIERIS PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2021 | PIRS | PIERIS PHARMACEUTI ... | Sherman Matthew L | Option Exercise | A | 4.00 | 40,000 | 160,000 | 40,000 | ||
Jun 29 2021 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Option Exercise | A | 4.00 | 40,000 | 160,000 | 40,000 | ||
Mar 08 2021 | PIRS | PIERIS PHARMACEUTI ... | Bures Thomas | Vice President, Fin ... | Option Exercise | A | 2.50 | 150,000 | 375,000 | 150,000 | |
Mar 08 2021 | PIRS | PIERIS PHARMACEUTI ... | Kaufmann Hitto | SVP, Chief Scientif ... | Option Exercise | A | 2.50 | 220,000 | 550,000 | 220,000 | |
Mar 08 2021 | PIRS | PIERIS PHARMACEUTI ... | Yoder Stephen S. | Chief Executive Off ... | Option Exercise | A | 2.50 | 530,000 | 1,325,000 | 530,000 | |
Jul 22 2020 | PIRS | PIERIS PHARMACEUTI ... | Aquilo Capital Management, LLC | 10% Owner | Sell | S | 2.95 | 1,900,000 | 5,605,000 | 3,675,530 | 5.6 M to 3.7 M (-34.08 %) |
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Said Maya R. | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Said Maya R. | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Sherman Matthew L | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Sherman Matthew L | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Option Exercise | A | 3.27 | 45,000 | 147,150 | 45,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Barbier Ann | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Option Exercise | A | 3.27 | 45,000 | 147,150 | 45,000 | ||
Jun 25 2020 | PIRS | PIERIS PHARMACEUTI ... | Barbier Ann | Option Exercise | A | 3.27 | 40,000 | 130,800 | 40,000 | ||
Mar 02 2020 | PIRS | PIERIS PHARMACEUTI ... | Bures Thomas | Vice President, Fin ... | Option Exercise | A | 3.15 | 80,000 | 252,000 | 80,000 | |
Mar 02 2020 | PIRS | PIERIS PHARMACEUTI ... | Kaufmann Hitto | SVP, Chief Scientif ... | Option Exercise | A | 3.15 | 45,000 | 141,750 | 45,000 | |
Mar 02 2020 | PIRS | PIERIS PHARMACEUTI ... | Yoder Stephen S. | Chief Executive Off ... | Option Exercise | A | 3.15 | 420,000 | 1,323,000 | 420,000 | |
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Said Maya R. | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Barbier Ann | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Sherman Matthew L | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 3.23 | 20,000 | 64,600 | 20,000 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 3.23 | 5,431 | 17,542 | 5,431 | ||
Jan 28 2020 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Option Exercise | A | 3.23 | 22,500 | 72,675 | 22,500 | ||
Oct 28 2019 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 3.24 | 5,165 | 16,735 | 5,165 | ||
Oct 28 2019 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 3.24 | 5,165 | 16,735 | 5,165 | ||
Sep 10 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.50 | 1,128 | 5,075 | 314,139 | 315.3 K to 314.1 K (-0.36 %) |
Sep 10 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.50 | 25,720 | 115,725 | 2,233,074 | 2.3 M to 2.2 M (-1.14 %) |
Sep 10 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.50 | 23,152 | 104,170 | 2,385,055 | 2.4 M to 2.4 M (-0.96 %) |
Sep 03 2019 | PIRS | PIERIS PHARMACEUTI ... | Kaufmann Hitto | SVP, Chief Scientif ... | Option Exercise | A | 4.65 | 300,000 | 1,395,000 | 300,000 | |
Aug 01 2019 | PIRS | PIERIS PHARMACEUTI ... | Said Maya R. | Option Exercise | A | 5.50 | 30,000 | 165,000 | 30,000 | ||
Jul 26 2019 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 4.40 | 3,789 | 16,672 | 3,789 | ||
Apr 30 2019 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 2.94 | 5,640 | 16,582 | 5,640 | ||
Apr 30 2019 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 2.94 | 5,640 | 16,582 | 5,640 | ||
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | J | 0.00 | 284 | 0 | 284 | |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | J | 0.00 | 2,143 | 0 | 2,143 | |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | J | 0.00 | 2,573 | 0 | 2,573 | |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | J | 0.00 | 284,000 | 0 | 141,346 | 425.3 K to 141.3 K (-66.77 %) |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | J | 0.00 | 2,143,000 | 0 | 772,324 | 2.9 M to 772.3 K (-73.51 %) |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | J | 0.00 | 2,573,000 | 0 | 978,200 | 3.6 M to 978.2 K (-72.45 %) |
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Sherman Matthew L | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 2.74 | 6,096 | 16,703 | 6,096 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Prelack Steven | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | BIZZARI JEAN-PIERRE | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | Barbier Ann | Option Exercise | A | 2.74 | 20,000 | 54,800 | 20,000 | ||
Jan 29 2019 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Option Exercise | A | 2.74 | 25,000 | 68,500 | 25,000 | ||
Oct 29 2018 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 4.36 | 3,829 | 16,694 | 3,829 | ||
Oct 25 2018 | PIRS | PIERIS PHARMACEUTI ... | Sherman Matthew L | Option Exercise | A | 4.46 | 30,000 | 133,800 | 30,000 | ||
Oct 25 2018 | PIRS | PIERIS PHARMACEUTI ... | Kiener Peter A | Option Exercise | A | 4.46 | 30,000 | 133,800 | 30,000 | ||
Sep 17 2018 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Buy | P | 5.11 | 5,000 | 25,525 | 10,000 | 5 K to 10 K (+100.00 %) | |
Jul 26 2018 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 5.92 | 2,837 | 16,795 | 2,837 | ||
May 16 2018 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Buy | P | 5.75 | 10,000 | 57,500 | 20,000 | 10 K to 20 K (+100.00 %) | |
May 02 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 6.35 | 10,400 | 66,040 | 38,870 | 49.3 K to 38.9 K (-21.11 %) |
May 02 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 6.35 | 989,600 | 6,283,960 | 4,511,130 | 5.5 M to 4.5 M (-17.99 %) |
Apr 26 2018 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 6.43 | 2,665 | 17,136 | 2,665 | ||
Apr 26 2018 | PIRS | PIERIS PHARMACEUTI ... | Barbier Ann | Option Exercise | A | 6.43 | 30,000 | 192,900 | 30,000 | ||
Feb 26 2018 | PIRS | PIERIS PHARMACEUTI ... | Matis Louis | Chief Development O ... | Option Exercise | A | 8.56 | 100,000 | 856,000 | 100,000 | |
Feb 26 2018 | PIRS | PIERIS PHARMACEUTI ... | Reine Allan | Chief Financial Off ... | Option Exercise | A | 5.00 | 50,000 | 250,000 | 50,000 | |
Feb 26 2018 | PIRS | PIERIS PHARMACEUTI ... | Reine Allan | Chief Financial Off ... | Option Exercise | A | 8.56 | 53,833 | 460,810 | 53,833 | |
Feb 26 2018 | PIRS | PIERIS PHARMACEUTI ... | Yoder Stephen S. | Chief Executive Off ... | Option Exercise | A | 8.56 | 325,000 | 2,782,000 | 325,000 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.08 | 17 | 86 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.08 | 1,765 | 8,966 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 4.68 | 58 | 271 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 4.68 | 6,057 | 28,347 | 0 | |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 8.98 | 75 | 674 | 49,270 | 49.3 K to 49.3 K (-0.15 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 8.98 | 7,822 | 70,242 | 5,500,730 | 5.5 M to 5.5 M (-0.14 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.08 | 17 | 86 | 49,345 | 49.3 K to 49.3 K (+0.03 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.08 | 1,765 | 8,966 | 5,508,552 | 5.5 M to 5.5 M (+0.03 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 4.68 | 58 | 271 | 49,328 | 49.3 K to 49.3 K (+0.12 %) |
Feb 15 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 4.68 | 6,057 | 28,347 | 5,506,787 | 5.5 M to 5.5 M (+0.11 %) |
Jan 04 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.35 | 16,128 | 118,541 | 49,270 | 65.4 K to 49.3 K (-24.66 %) |
Jan 04 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.35 | 1,693,492 | 12,447,166 | 5,500,730 | 7.2 M to 5.5 M (-23.54 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.64 | 47 | 265 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 5.64 | 4,971 | 28,036 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.32 | 99 | 230 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.32 | 10,447 | 24,237 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 97 | 195 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 10,216 | 20,534 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 142 | 285 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.01 | 14,858 | 29,865 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.64 | 97 | 159 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.64 | 10,182 | 16,698 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.73 | 92 | 159 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.73 | 9,642 | 16,681 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.05 | 77 | 158 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.05 | 8,097 | 16,599 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.59 | 189 | 301 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.59 | 19,811 | 31,499 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.62 | 97 | 157 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.62 | 10,180 | 16,492 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.94 | 83 | 161 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 1.94 | 8,717 | 16,911 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.62 | 63 | 165 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.62 | 6,654 | 17,433 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 3.00 | 50 | 150 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 3.00 | 5,227 | 15,681 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.00 | 259 | 518 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | M | 2.00 | 27,241 | 54,482 | 0 | |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 5.70 | 1,392 | 7,934 | 65,398 | 66.8 K to 65.4 K (-2.08 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 5.70 | 146,243 | 833,585 | 7,194,222 | 7.3 M to 7.2 M (-1.99 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.64 | 47 | 265 | 66,790 | 66.7 K to 66.8 K (+0.07 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 5.64 | 4,971 | 28,036 | 7,340,465 | 7.3 M to 7.3 M (+0.07 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.32 | 99 | 230 | 66,743 | 66.6 K to 66.7 K (+0.15 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.32 | 10,447 | 24,237 | 7,335,494 | 7.3 M to 7.3 M (+0.14 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 97 | 195 | 66,644 | 66.5 K to 66.6 K (+0.15 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 10,216 | 20,534 | 7,325,047 | 7.3 M to 7.3 M (+0.14 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 142 | 285 | 66,547 | 66.4 K to 66.5 K (+0.21 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.01 | 14,858 | 29,865 | 7,314,831 | 7.3 M to 7.3 M (+0.20 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.64 | 97 | 159 | 66,405 | 66.3 K to 66.4 K (+0.15 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.64 | 10,182 | 16,698 | 7,299,973 | 7.3 M to 7.3 M (+0.14 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.73 | 92 | 159 | 66,308 | 66.2 K to 66.3 K (+0.14 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.73 | 9,642 | 16,681 | 7,289,791 | 7.3 M to 7.3 M (+0.13 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.05 | 77 | 158 | 66,216 | 66.1 K to 66.2 K (+0.12 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.05 | 8,097 | 16,599 | 7,280,149 | 7.3 M to 7.3 M (+0.11 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.59 | 189 | 301 | 66,139 | 66 K to 66.1 K (+0.29 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.59 | 19,811 | 31,499 | 7,272,052 | 7.3 M to 7.3 M (+0.27 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.62 | 97 | 157 | 65,950 | 65.9 K to 66 K (+0.15 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.62 | 10,180 | 16,492 | 7,252,241 | 7.2 M to 7.3 M (+0.14 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.94 | 83 | 161 | 65,853 | 65.8 K to 65.9 K (+0.13 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 1.94 | 8,717 | 16,911 | 7,242,061 | 7.2 M to 7.2 M (+0.12 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.62 | 63 | 165 | 65,770 | 65.7 K to 65.8 K (+0.10 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.62 | 6,654 | 17,433 | 7,233,344 | 7.2 M to 7.2 M (+0.09 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 3.00 | 50 | 150 | 65,707 | 65.7 K to 65.7 K (+0.08 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 3.00 | 5,227 | 15,681 | 7,226,690 | 7.2 M to 7.2 M (+0.07 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.00 | 259 | 518 | 65,657 | 65.4 K to 65.7 K (+0.40 %) |
Dec 20 2017 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | M | 2.00 | 27,241 | 54,482 | 7,221,463 | 7.2 M to 7.2 M (+0.38 %) |
Dec 14 2017 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Option Exercise | A | 5.79 | 40,000 | 231,600 | 40,000 | ||
Oct 27 2017 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Option Exercise | A | 4.68 | 4,006 | 18,748 | 4,006 | ||
Oct 27 2017 | PIRS | PIERIS PHARMACEUTI ... | Khuong Chau Quang | Option Exercise | A | 4.68 | 6,115 | 28,618 | 6,115 | ||
Aug 17 2017 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Director | Buy | P | 4.82 | 10,000 | 48,200 | 10,000 | 0 to 10 K |
Aug 17 2017 | PIRS | PIERIS PHARMACEUTI ... | Reine Allan | See Remarks | Buy | P | 4.89 | 20,000 | 97,800 | 65,000 | 45 K to 65 K (+44.44 %) |
Aug 17 2017 | PIRS | PIERIS PHARMACEUTI ... | Reine Allan | See Remarks | Buy | P | 4.79 | 45,000 | 215,550 | 45,000 | 0 to 45 K |
Aug 11 2017 | PIRS | PIERIS PHARMACEUTI ... | Reine Allan | See Remarks | Option Exercise | A | 5.00 | 450,000 | 2,250,000 | 450,000 | |
Jul 27 2017 | PIRS | PIERIS PHARMACEUTI ... | Khuong Chau Quang | Director | Option Exercise | A | 5.64 | 5,018 | 28,302 | 5,018 | |
Jul 27 2017 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Director | Option Exercise | A | 5.64 | 3,288 | 18,544 | 3,288 | |
May 24 2017 | PIRS | PIERIS PHARMACEUTI ... | GERAGHTY JAMES A | Director | Option Exercise | A | 3.94 | 30,000 | 118,200 | 30,000 | |
May 09 2017 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Director | Option Exercise | M | 1.59 | 5,000 | 7,950 | 25,000 | |
May 09 2017 | PIRS | PIERIS PHARMACEUTI ... | KIRITSY CHRISTOPHER P | Director | Buy | M | 1.59 | 5,000 | 7,950 | 5,000 | 0 to 5 K |
Apr 27 2017 | PIRS | PIERIS PHARMACEUTI ... | Khuong Chau Quang | Director | Option Exercise | A | 2.32 | 10,546 | 24,467 | 10,546 | |
Apr 27 2017 | PIRS | PIERIS PHARMACEUTI ... | Richman Michael | Director | Option Exercise | A | 2.32 | 7,821 | 18,145 | 7,821 |